1.
Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial
by Fayad, Zahi A, Prof
The Lancet (British edition), 2011, Vol.378 (9802), p.1547-1559

2.
Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis
by Xie, Xinfang, MD
The Lancet (British edition), 2016, Vol.387 (10017), p.435-443

3.
Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes
by Zoungas, Sophia
Diabetologia, 2014, Vol.57 (12), p.2465-2474

4.

5.
Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all-cause mortality
by Anderson, Simon G
Heart (British Cardiac Society), 2016, Vol.102 (21), p.1750-1756

6.
Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens
by Fransen, Marlene
Annals of the rheumatic diseases, 2015, Vol.74 (5), p.851-858

7.
Rationale and design of dal-PLAQUE: A study assessing efficacy and safety of dalcetrapib on progression or regression of atherosclerosis using magnetic resonance imaging and 18F-fl...
by Fayad, Zahi A., PhD
The American heart journal, 2011, Vol.162 (2), p.214-221.e2

8.
Predictors of Low Clopidogrel Adherence Following Percutaneous Coronary Intervention
by Muntner, Paul, PhD
The American journal of cardiology, 2011, Vol.108 (6), p.822-827

9.
Rapid Blood Pressure Lowering According to Recovery at Different Time Intervals after Acute Intracerebral Hemorrhage: Pooled Analysis of the INTERACT Studies
by Wang, Xia
Cerebrovascular diseases (Basel, Switzerland), 2015, Vol.39 (3-4), p.242-248

10.
Predictors of change in carotid atherosclerotic plaque inflammation and burden as measured by 18-FDG-PET and MRI, respectively, in the dal-PLAQUE study
by Mani, Venkatesh
The International Journal of Cardiovascular Imaging, 2014, Vol.30 (3), p.571-582

11.
Effectiveness of blood pressure lowering: evidence-based comparisons between men and women
by Turnbull, Fiona
Expert review of cardiovascular therapy, 2010, Vol.8 (2), p.199-209

12.
Magnitude of blood pressure reduction and clinical outcomes in acute intracerebral hemorrhage: intensive blood pressure reduction in acute cerebral hemorrhage trial study
by Wang, Xia
Hypertension (Dallas, Tex. 1979), 2015, Vol.65 (5), p.1026-1032

13.
Predicting the effects of blood pressure-lowering treatment on major cardiovascular events for individual patients with type 2 diabetes mellitus results from action in diabetes and...
by Van Der Leeuw, Joep
Hypertension (Dallas, Tex. 1979), 2015, Vol.65 (1), p.115-121

14.
Lower Treatment Blood Pressure Is Associated With Greatest Reduction in Hematoma Growth After Acute Intracerebral Hemorrhage
by Arima, Hisatomi
Hypertension (Dallas, Tex. 1979), 2010, Vol.56 (5), p.852-858

15.
Blood Pressure Variables and Cardiovascular Risk: New Findings From ADVANCE
by Kengne, Andre-Pascal
Hypertension (Dallas, Tex. 1979), 2009, Vol.54 (2), p.399-404

16.
The ACE gene I/D polymorphism is not associated with the blood pressure and cardiovascular benefits of ACE inhibition
by HARRAP, Stephen B
Hypertension (Dallas, Tex. 1979), 2003, Vol.42 (3), p.297-303

17.
Web based pathology assessment in RTOG 98-04
by Woodward, Wendy A
Journal of clinical pathology, 2014, Vol.67 (9), p.777-780

18.
Symptom changes in five dimensions of the Positive and Negative Syndrome Scale in refractory psychosis
by Woodward, T.S
European archives of psychiatry and clinical neuroscience, 2014, Vol.264 (8), p.673-682

19.
Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic review
by Chow, Clara K, Prof
The Lancet (British edition), 2017, Vol.389 (10073), p.1035-1042

20.
Ritonavir-boosted lopinavir plus nucleoside or nucleotide reverse transcriptase inhibitors versus ritonavir-boosted lopinavir plus raltegravir for treatment of HIV-1 infection in a...
by Boyd, M A
The Lancet (British edition), 2013, Vol.381 (9883), p.2091-2099
